In contrast to TGFβ1, activin A treatment of NHDF results in a weaker XYLT1 mRNA expression increase, which can be explained by the autocrine TGFβ1 signalling, which is responsible for sustaining or amplifying the fibrotic responses in the pathogenesis of SSc [7]. Here, XYLT1 is linked to systemic sclerosis.